Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial

Autor: Marion Sumari-de Boer, Francis M. Pima, Kennedy M. Ngowi, Geoffrey M. Chelangwa, Benson A. Mtesha, Linda M. Minja, Hadija H. Semvua, Stella Mpagama, Blandina T. Mmbaga, Pythia T. Nieuwkerk, Rob E. Aarnoutse

Publikováno v: Trials, Vol 20, Iss 1, Pp 1-10 (2019)

Abstract Background Adherence to tuberculosis (TB) treatment is challenging because of many factors. The World Health Organization has recommended the use of digital adherence monitoring technologies in its End TB Strategy. However, evidence on impro

Externí odkaz: https://doaj.org/article/e06a9e38f4ba456fa98b08993a5ee692

Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial

Autor: Stella Mpagama, Hadija H. Semvua, Linda Minja, Benson Mtesha, Marion Sumari-de Boer, Kennedy Ngowi, Francis Pima, Pythia T. Nieuwkerk, Blandina T. Mmbaga, Rob E. Aarnoutse, Geoffrey M. Chelangwa

Publikováno v: Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Trials, 20(1):426. BioMed Central
Trials

Background Adherence to tuberculosis (TB) treatment is challenging because of many factors. The World Health Organization has recommended the use of digital adherence monitoring technologies in its End TB Strategy. However, evidence on improving adhe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08370f35faee89defb182194e6533cde
https://doi.org/10.1186/s13063-019-3483-4

Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania.

Autor: Anenmose Maro R; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.; Nelson Mandela African Institute of Science and Technology, Arusha, Tanzania., Mtenga A; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.; Nelson Mandela African Institute of Science and Technology, Arusha, Tanzania., Mtesha B; Kilimanjaro Clinical Research Institute, Moshi, Tanzania., Wilhelm K; Kilimanjaro Clinical Research Institute, Moshi, Tanzania., Lekashingo N; Kilimanjaro Clinical Research Institute, Moshi, Tanzania., Sumari-de Boer M; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.; Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.; Kilimanjaro Christian Medical Univesity Collage, Moshi, Tanzania.; Knowledge, Innovation & Technology Group at Wageningen & University Research, the Netherlands., Ngowi K; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.

Publikováno v: Journal of clinical tuberculosis and other mycobacterial diseases [J Clin Tuberc Other Mycobact Dis] 2023 Dec 03; Vol. 34, pp. 100409. Date of Electronic Publication: 2023 Dec 03 (Print Publication: 2024).